PD-1 blockade plus cisplatin-based chemotherapy in patients with small cell/neuroendocrine bladder and prostate cancers

By sjmartinez • November 14, 2024

Gu Y, Ly A, Rodriguez S, Zhang H, Kim J, Mao Z, Sachdeva A, Zomorodian N, Pellegrini M, Li G, Liu S, Drakaki A, Rettig MB, Chin AI. PD-1 blockade plus cisplatin-based chemotherapy in patients with small cell/neuroendocrine bladder and prostate cancers. Cell Rep Med. 2024 Nov 6:101824. doi: 10.1016/j.xcrm.2024.101824. Epub ahead of print. PMID: 39536751.

Tags: Clinical Trial, Dermatology, Hematology/Oncology, immunochemotherapy, neuroendocrine prostate cancer, PD-1 blockade, Publications, single-cell sequencing, small cell bladder cancer, small cell cancers, T cell receptor sequencing, Veterans Administration

Seq-Scope-eXpanded: spatial omics beyond optical resolution

Anacleto A, Cheng W, Feng Q, Park A, Cho CS, Hwang Y, Kim Y, Si Y, Hsu JE, Zhao Q, Zhao X, Kim D, Schrank[...]

Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United States

Silverberg JI, Cohen D, Guttman-Yassky E, Eichenfield LF, Simpson EL, Armstrong A, Yu J, Stein-Gold L, Ehst BD, Begolka WS, Bunick CG, Chovatiya R. Expert[...]

Effects of GLP-1 Receptor Agonists on Major Cardiovascular Events Among Patients with Atopic Dermatitis: A Population-Based Study

Katz A, Nong Y, Ma EJ, Roberts AM, Chou PP, Jeong CY, Yan MJ, Johnsen N, Armstrong AW. Effects of GLP-1 Receptor Agonists on Major[...]